Michael John Rathbone
Overview
Explore the profile of Michael John Rathbone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
94
Followers
0
Related Specialty
Related Specialty
Co-Authors
Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Awasthi R, Roseblade A, Hansbro P, Rathbone M, Dua K, Bebawy M
Curr Drug Targets
. 2018 Mar;
19(14):1696-1709.
PMID: 29577855
In the United States, the estimated number of new cancer cases in 2018 will be approx. 1.7 million. Historically, combination chemotherapy has been the primary choice of treatment. However, chemotherapeutics...
2.
Awasthi R, Rathbone M, Hansbro P, Bebawy M, Dua K
Drug Deliv Transl Res
. 2017 Nov;
8(1):97-110.
PMID: 29185148
MicroRNAs (miRNAs) represent a new class of diagnostic and prognostic biomarker as well as new therapeutic targets in cancer therapy. miRNAs are gaining significant interest due to extensive advancements in...
3.
Rathbone M, Wang C, Kataoka K
J Control Release
. 2014 Sep;
193:1.
PMID: 25217812
No abstract available.
4.
Wong T, Dhanawat M, Rathbone M
Expert Opin Drug Deliv
. 2014 Jun;
11(9):1419-34.
PMID: 24960192
Introduction: Vaginal infection is widespread and > 80% of females encounter such infections during their lives. Topical treatment and prevention of vaginal infection allows direct therapeutic action, reduced drug doses...